Management of High-Dose Prednisone for Rheumatic Valve Flare and Deprescribing

Initial Tapering Phase

• The European League Against Rheumatism recommends beginning with reducing the high-dose prednisone gradually to reach 10 mg/day within 4-8 weeks, while monitoring for disease activity and adverse events 1, 2, 4
• Single daily dosing is preferred over divided doses to minimize adrenal suppression, as suggested by the American College of Rheumatology 2

Maintenance Tapering Phase

• The American College of Rheumatology recommends tapering by 1 mg every 4 weeks until discontinuation, once a stable dose of 10 mg/day is achieved and remission is maintained 1, 2
• For doses below 5 mg/day, consider split dosing if night pain becomes prominent, as recommended by the European League Against Rheumatism 2, 4

Monitoring During Tapering

• The American College of Rheumatology suggests following patients every 4-8 weeks during the first year of treatment, then every 8-12 weeks in the second year, to monitor for disease activity and adverse events 2, 4
• Monitor inflammatory markers and clinical symptoms to assess for disease activity, as recommended by the European League Against Rheumatism 5

Managing Relapse During Tapering

• If relapse occurs, increase prednisone to the pre-relapse dose, then gradually decrease within 4-8 weeks to the dose at which relapse occurred, as suggested by the American College of Rheumatology 2
• Consider adding methotrexate (7.5-10 mg/week) as a steroid-sparing agent if multiple relapses occur or prolonged therapy is needed, as recommended by the European League Against Rheumatism 1, 2

Special Considerations

• For patients with frequent relapses despite appropriate tapering, intramuscular methylprednisolone can be considered as an alternative to oral glucocorticoids, as suggested by the American College of Rheumatology 1, 2
• If insufficient improvement occurs within 2 weeks of initial therapy, consider increasing the oral dose up to 25 mg prednisone, as recommended by the European League Against Rheumatism 4

Pitfalls to Avoid

• Using doses >30 mg/day for extended periods significantly increases risk of adverse effects without proportional therapeutic benefit, as warned by the American College of Rheumatology 1, 5